---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-151254"
form_type: "8-K"
ticker: "RVMD"
cik: "0001628171"
company_name: "Revolution Medicines, Inc."
filed_at: "2025-06-27T23:59:59+00:00"
generated_at: "2026-05-18T15:55:12.774014+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Revolution Medicines stockholders elect four Class II directors, ratify PwC, approve say-on-pay at 2025 annual meeting

## Summary
- Directors elected: Frank Clyburn, Sandra Horning, Sushil Patel, Thilo Schroeder; each received >119M votes for.
- Ratified PricewaterhouseCoopers as independent auditor for FY2025 with 157.9M votes for, 215K against.
- Advisory say-on-pay approved with 145.3M votes for, 2.6M against, 10.2M broker non-votes.
- Record date April 28, 2025; 186.3M shares outstanding and entitled to vote.

## SEC filing metadata
- accession: 0001193125-25-151254
- form_type: 8-K
- ticker: RVMD
- cik: 0001628171
- company_name: Revolution Medicines, Inc.
- filed_at: 2025-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628171/000119312525151254/0001193125-25-151254-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628171/000119312525151254/d12458d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-151254
- JSON: https://secwatch.observer/filing/0001193125-25-151254.json
- Plain text: https://secwatch.observer/filing/0001193125-25-151254.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.